Literature DB >> 10169384

Publication bias in clinical trials and economic analyses.

N Freemantle1, J Mason.   

Abstract

Publication bias is an established notion in the clinical literature; essentially, large studies or positive results are more likely to find their way into the public domain than small studies or negative results. Meta-analysis presents a focus for the problems of publication bias, seeking to summarise the evidence in a particular therapeutic area by retrieving and analysing all available clinical studies. Economic analyses are also vulnerable to publication bias, and at 3 levels: first, in the health-outcomes data available for modelling (resulting from publication bias in the clinical literature); second, in the motivations for conducting an economic analysis; and third, in repeating the process of seeking publication.

Mesh:

Substances:

Year:  1997        PMID: 10169384     DOI: 10.2165/00019053-199712010-00002

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  27 in total

1.  The DH register of cost-effectiveness studies: content and quality.

Authors:  J Mason; M Drummond
Journal:  Health Trends       Date:  1995

2.  Misleading meta-analysis.

Authors:  M Egger; G D Smith
Journal:  BMJ       Date:  1995-09-16

3.  Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis.

Authors:  P C Gøtzsche
Journal:  Control Clin Trials       Date:  1989-03

4.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

5.  Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis.

Authors:  I M Anderson; B M Tomenson
Journal:  BMJ       Date:  1995-06-03

6.  Economic analysis of health care technology. A report on principles. Task Force on Principles for Economic Analysis of Health Care Technology.

Authors: 
Journal:  Ann Intern Med       Date:  1995-07-01       Impact factor: 25.391

Review 7.  Identifying relevant studies for systematic reviews.

Authors:  K Dickersin; R Scherer; C Lefebvre
Journal:  BMJ       Date:  1994-11-12

8.  Intravenous magnesium in acute myocardial infarction. An effective, safe, simple, and inexpensive intervention.

Authors:  S Yusuf; K Teo; K Woods
Journal:  Circulation       Date:  1993-06       Impact factor: 29.690

9.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

10.  Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.

Authors:  F Song; N Freemantle; T A Sheldon; A House; P Watson; A Long; J Mason
Journal:  BMJ       Date:  1993-03-13
View more
  8 in total

Review 1.  Assessing the quality of pharmacoeconomic studies in India: a systematic review.

Authors:  Pooja R Desai; Hitesh S Chandwani; Karen L Rascati
Journal:  Pharmacoeconomics       Date:  2012-09-01       Impact factor: 4.981

Review 2.  The generalisability of pharmacoeconomic studies.

Authors:  J Mason
Journal:  Pharmacoeconomics       Date:  1997-06       Impact factor: 4.981

Review 3.  The state of health economic evaluation research in Nigeria: a systematic review.

Authors:  Paul Gavaza; Karen L Rascati; Abiola O Oladapo; Star Khoza
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

Review 4.  Bias in published cost effectiveness studies: systematic review.

Authors:  Chaim M Bell; David R Urbach; Joel G Ray; Ahmed Bayoumi; Allison B Rosen; Dan Greenberg; Peter J Neumann
Journal:  BMJ       Date:  2006-02-22

Review 5.  Transparency in Decision Modelling: What, Why, Who and How?

Authors:  Christopher James Sampson; Renée Arnold; Stirling Bryan; Philip Clarke; Sean Ekins; Anthony Hatswell; Neil Hawkins; Sue Langham; Deborah Marshall; Mohsen Sadatsafavi; Will Sullivan; Edward C F Wilson; Tim Wrightson
Journal:  Pharmacoeconomics       Date:  2019-11       Impact factor: 4.981

Review 6.  Do economic evaluation studies inform effective healthcare resource allocation in Iran? A critical review of the literature.

Authors:  Hassan Haghparast-Bidgoli; Aliasghar Ahmad Kiadaliri; Jolene Skordis-Worrall
Journal:  Cost Eff Resour Alloc       Date:  2014-07-11

7.  Model Registration: A Call to Action.

Authors:  Christopher James Sampson; Tim Wrightson
Journal:  Pharmacoecon Open       Date:  2017-06

8.  The economics of primary prevention of cardiovascular disease - a systematic review of economic evaluations.

Authors:  David Lb Schwappach; Till A Boluarte; Marc Suhrcke
Journal:  Cost Eff Resour Alloc       Date:  2007-05-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.